Balance Sheet Data
Pieris Pharmaceuticals, Inc. (PIRS)
$0.2043
+0.00 (+2.10%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 128.11 | 104.15 | 70.44 | 117.76 | 59.17 | 80.50 | 82.91 | 85.39 | 87.95 | 90.58 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 2.70 | 6.79 | 1.71 | 3.31 | 5.81 | 3.35 | 3.45 | 3.55 | 3.66 | 3.77 |
| Account Receivables (%) | ||||||||||
| Inventories | - | - | - | - | - | - | - | - | - | - |
| Inventories (%) | ||||||||||
| Accounts Payable | 3.35 | 10.05 | 3.01 | 8.61 | 4.15 | 4.64 | 4.78 | 4.92 | 5.07 | 5.22 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -1.70 | -2.46 | -2.73 | -0.95 | -1.04 | -1.47 | -1.51 | -1.56 | -1.60 | -1.65 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.